Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.
Press releases published on April 30, 2025
Nexxen to Announce First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for the …
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 14th, 2025
GlobeNewswire
·
April 30, 2025
MONTREAL, April 30, 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its third quarter ended March 31st, 2025, on Wednesday, May 14, 2025, at 10:00 a.m. Eastern Time. …
NanoXplore organise une webdiffusion pour discuter des résultats du troisième trimestre le 14 mai 2025
GlobeNewswire
·
April 30, 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (" NanoXplore " ou la " Société ") (TSX : GRA et OTCQX : NNXPF) a le plaisir d'organiser une webdiffusion pour discuter des résultats de son troisième trimestre clos le 31 mars 2025, le mercredi 14 …
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, May 5, 2025, at 8:30 AM ET to discuss results for the first quarter of 2025 and provide a business outlook for …
Altimmune to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
GAITHERSBURG, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Citizens Life …
Cielo Announces Settlement Agreement and Shareholder Meeting
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) (“Cielo” or the “Company”) is pleased to announce that it has reached an agreement (the “Settlement Agreement”) with Expander Energy Inc. (“ …
InflaRx to Report First Quarter 2025 Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
JENA, Germany, April 30, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will report its first quarter 2025 financial …
ParaZero and Heven Drones Receive the Israeli Ministry of Defense Approval to Market Globally DropAir Precision Airdrop System
GlobeNewswire
·
April 30, 2025
TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announced recently …
Brookfield Infrastructure Reports Solid First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
BROOKFIELD, News, April 30, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the first quarter ended March 31, 2025. “We delivered …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …
Gauzy Ltd. Sets Date for First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in light and vision control technologies, today announced it will release financial results for the first quarter ended March 31, …
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …
NodThera’s Oral NLRP3 Inhibitor NT-0796 Enhances and Sustains Weight Loss in Combination with GLP-1
GlobeNewswire
·
April 30, 2025
Data published in Obesity journal show enhanced weight loss effect of NT-0796 when combined with semaglutide in preclinical obesity model Obese state completely reversed with 30% weight loss and reversal of hypothalamic inflammation NT-0796 sustained …
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
GlobeNewswire
·
April 30, 2025
Sanofi and CD…
Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public
GlobeNewswire
·
April 30, 2025
Sanofi et CD…
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer …
Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
GlobeNewswire
·
April 30, 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Stingray to Release its Financial Results for the Fourth Quarter of Fiscal 2025
GlobeNewswire
·
April 30, 2025
MONTREAL, April 30, 2025 (GLOBE NEWSWIRE) -- Stingray Group Inc. (TSX: RAY.A; RAY.B) will release its financial results for the fourth quarter ended March 31, 2025, on Tuesday, June 10, 2025, after the markets close. Management will hold a conference call …
Stingray publiera ses résultats financiers pour le quatrième trimestre de l’exercice 2025
GlobeNewswire
·
April 30, 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- Le Groupe Stingray Inc. (TSX: RAY.A; RAY.B) publiera ses résultats financiers pour le quatrième trimestre clos le 31 mars 2025, le mardi 10 juin 2025, après la fermeture des marchés financiers. La direction …